Sukcesywna dostawa leku do programu lekowego - Nusinersen
TED · 788554-2026Contract noticeCloses in 27 days · 2026-12-11
Value
Estimated—
Awarded—
Who already wins at this buyer
Firms with recorded awards from Instytut Psychiatrii i Neurologii in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| CSL Behring Sp. z o.o. | 1 | €3,142,916 | 2026-07-23 |
| Urtica Sp. z o. o. | 1 | €2,898,906 | 2026-06-11 |
| Medtronic Poland Sp. z o.o. | Boston Scientific Polska Sp. z o.o. | 1 | €2,786,222 | 2026-11-13 |
| Urtica sp. z o.o. | 1 | €1,087,093 | 2026-06-11 |
| Roche Polska Sp. z o.o. | 1 | €1,015,993 | 2026-07-24 |
Full buyer profile: what Instytut Psychiatrii i Neurologii buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticals33661000 Medical equipment & pharmaceuticalsDescription
Nusinersen 28 mg/5 ml oraz Nusinersen 50 mg/5 ml
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-25 | Sukcesywna dostawa leków do programów lekowych – 5 pakietów | Instytut Psychiatrii i Neurologii PL | 93% |
| 2026-06-11 | Sukcesywna dostawa leku do programu lekowego - Omaveloxolonum | Instytut Psychiatrii i Neurologii PL | 93% |
| 2026-07-24 | Sukcesywna dostawa leku do programu lekowego – Risdiplamum | Instytut Psychiatrii i Neurologii PL | 93% |
| 2026-05-18 | Sukcesywna dostawa leku do programu lekowego – Agalsidase alfa | Instytut Psychiatrii i Neurologii PL | 93% |
| 2026-07-23 | Sukcesywna dostawa leku do programu lekowego – Immunoglobulin Humanum | Instytut Psychiatrii i Neurologii PL | 92% |
| 2026-09-30 | Sukcesywna dostawa leków – 2 pakiety | Instytut Psychiatrii i Neurologii PL | 92% |